06669.HK
Acotec Scientific Holdings Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 5.22
−6.37%Year over year
Reported trailing growth
- Revenue
- +5.4%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- -95.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +17.7%
- EBITDA
- +20.5%
- EBIT
- +22.7%
- Net income
- +19.3%
- EPS
- +19.2%
- Free cash flow
- +2638.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026